Mitsui Chemicals Completes its $900 Million Acquisition of Ultradent Products and Expands South Jordan's Role to Oversee the Growth and Dominance of its Global Dental Businesses, including Germany's Kulzer and Japan's Sun Medical

EXECUTIVE SUMMARY

✅ Mitsui Chemicals quietly completed its $900 million acquisition of South Jordan, Utah-based Ultradent Products on 14 August 2026, several weeks ahead of the September closing timetable originally announced.

✅ Effective 1 October 2026, the newly formed South Jordan-based MC Dental Holdings America will oversee and manage Mitsui Chemicals' entire oral-care business, which will include Ultradent, Germany-based Kulzer Group, and Japan-based Sun Medical.

✅ However, neither Kulzer nor Sun Medical is moving from their native countries. In fact, Mitsui Chemicals is strengthening Sun Medical operationally in Japan while transferring the global business-management layer above it and its other oral-care businesses to South Jordan.

✅ Last of all, Mitsui Chemicals expects to realize over $40 million in annual expenditure savings by fiscal 2030 through this new administrative / leadership layer in Utah. Its top objective as it integrates its leadership, products, sales networks, and geographic strengths to South Jordan is both massive and yet, ostensibly direct: becoming nothing short of the No. 2 leader in the global oral-care marketplace.

TOKYO, Japan and SOUTH JORDAN, Utah — 16 September 2026 — Tokyo-based Mitsui Chemicals (Tokyo Stock Exchange, 4183.T) has completed its $900 million acquisition of South Jordan, Utah-based Ultradent Products.

But the longer-term impact of this Utah-focused story became more clear after the deal closed.

Specifically, on 1 September 2026, Mitsui Chemicals announced that its newly formed South Jordan-based MC Dental Holdings America would begin to “oversee and manage the entire Oral Care business” of Mitsui Chemicals, something that would begin one month later on October 1st.

With its restructuring announcement, Mitsui Chemicals explicitly identified the three major dental businesses falling within that new Utah-based management structure:

🟢  Utah-based Ultradent,

🟢  Germany-based Kulzer Group, and (not reported previously),

🟢  Japan-based Sun Medical.

That disclosure adds a new dimension to the Ultradent acquisition reported by Utah Money Watch on 31 July 2026.

Then, less than three weeks later, Mitsui Chemicals announced on August 17th that it had completed the Ultradent acquisition three days earlier, on 14 August, after required competition-law and foreign-investment approvals and notifications were completed sooner than expected.

Originally, the $900 million transaction of Ultradent had been expected to close sometime in September.

South Jordan's Role Becomes Clearer

Mitsui Chemicals first disclosed its intent to acquire Ultradent in mid-June, followed up by a separate announcement in mid-July of plans to form MC Dental Holdings America in South Jordan as

the "global headquarters ... of (its) ... oral care business" with the intent of serving "... as the third pillar of (Mitsui's) Life & Healthcare solutions business."

What was not yet explicit at the time, however, was just how broad the influence of the South Jordan operations would become, but that changed on September 1st.

That was when Mitsui Chemicals said MC Dental Holdings America would oversee and manage its global oral-care business, specifically naming Ultradent, Kulzer, and Sun Medical as part of this new entity.

At the same time, Mitsui Chemicals said it would abolish its existing Oral Care Business Division in Japan and transfer that division's business-management functions to the South Jordan-based company effective the 1st of October.

In other words, Mitsui Chemicals was not merely creating another Utah holding-company address; rather, it planned to transfer a layer of global business authority to South Jordan.

How Sun Medical Changes the Story

The Sun Medical aspect of this strategy is particularly notable because Mitsui Chemicals is simultaneously strengthening this Japanese company/subsidiary at home.

Specifically, on 15 July (one day after announcing details surrounding its U.S. holding-company structure), Mitsui Chemicals said it would consolidate its Japanese dental 3D-printing business and portions of its dental-materials business into Sun Medical.

That restructuring includes transferring Kulzer Japan's dental 3D printers and dental 3D-printing materials business to Sun Medical and concentrating related Japanese development, manufacturing, and sales capabilities there.

In announcing the move, Mitsui Chemicals described Sun Medical as the core of its dental 3D-printing business in Japan.

According to Sun Medical's corporate profile, the company remains headquartered in Moriyama, Shiga Prefecture, Japan, where it develops, manufactures and sells dental materials.

{AUTHOR'S NOTE: Mitsui Chemicals owns 50% of Sun Medical, while Nissin Dental Products owns 30% and Shofu holds the remaining 20%.}

So Mitsui Chemicals is not relocating Sun Medical itself to Utah.

Instead, it is strengthening Sun Medical as an operating and technology platform in Japan while moving the management layer above Sun Medical and its other global dental businesses to South Jordan.

The geographic logic becomes clearer in that structure.

According to Mitsui Chemicals' acquisition-completion announcement, Ultradent brings particular strength in teeth-whitening products and a strong operating base in the Americas, while Kulzer has an established position in restorative and prosthetic dentistry and a broader presence across Europe, the Middle East and Africa.

Sun Medical, meanwhile, provides products, technology, and operating capabilities in Japan, and (although not stated), provides regional strength for the entire APAC (Asia-Pacific) area.

Above those businesses, Mitsui Chemicals is positioning South Jordan as the management center for its global oral-care operations.

The Money and the Integration

According to Mitsui Chemicals' original acquisition disclosure, Ultradent generated $372.1 million in consolidated sales during 2025, along with $30.9 million in operating income and $24.0 million in net income.

At the announced $900 million transaction value, this means that Mitsui Chemicals paid the Ultradent owners roughly 2.4 times its 2025 revenue.

But the more important number now may be the financial return Mitsui Chemicals expects from integrating its oral-care businesses.

In its 17 August 2026 closing announcement, Mitsui Chemicals said it is targeting more than $40 million in annual synergistic benefits by fiscal 2030 through cross-selling, product development, operating efficiencies and other integration initiatives.

Management responsibilities are being integrated as well.

According to that same August 17th announcement, Ultradent President and CEO Dirk Jeffs is slated to serve concurrently as CEO of Kulzer, while Kulzer's current CEO, Chris Holden, is moving into the role of Chief Strategy and Integration Officer at MC Dental Holdings America.

And Mitsui Chemicals' oral-care executive, Shingo Ono, will relocate to the United States to serve as president of the South Jordan-based company.

A Different Kind of Utah Headquarters Win

The 31 July 2026 Utah Money Watch writeup — "Utah’s Ultradent Agrees to Be Acquired for $900 Million by Mitsui Chemicals, with a Global Dental Products HQ to be Established in South Jordan, Utah" — ended with four questions, three of which are now answered (at least partially):

1. Whether the acquisition closes on schedule? (Nope. It closed early.)
2. What functions land in South Jordan? (A lot, most notably the transfer of the global oral-care business-management functions to Utah.)
3. How visible (will) South Jordan become inside Mitsui Chemicals’ global oral-care structure? (Clearly, very, very visible, especially with Shingo Ono moving to Utah and serving as President of MC Dental Holdings America.)

That makes the $900 million Ultradent acquisition more than a Utah-company exit.

It also becomes the foundation for a new global corporate role for Utah inside Mitsui Chemicals.

For what purpose?

After re-examining each of the Ultradent-related investor and media announcements once again, it finally hit me:

The Mitsui Chemicals objective is to create the No. 2 global leader in the dental products and services industry. Period. Full stop.

And it plans to do so from South Jordan, Utah.

That ... that is what's happening here.

Clearly there will be oversight from Japan; one would not expect it to be otherwise.

That said, welcome to Utah, Mitsui Chemicals.

May you achieve your desired objective in the global dental products/services marketplace here.

Publisher's Note

Utah Money Watch reports and analyzes companies, transactions, securities, valuations and financial outcomes for informational and journalistic purposes. Nothing published by Utah Money Watch is intended as individualized investment advice or as a recommendation to buy, sell or hold any security.

That said, this writeup was originally published and distributed to our Subscribers at approximately 1:00pm MT on Wednesday, 16 September 2026.

However, if this report/article came to your attention sometime after this date/time and you'd like to change that, then (to become a subscriber), please 

1. Click on a "Subscribe" button on any Utah Money Watch webpage (visit www.UtahMoneyWatch.com),
2. Enter in your name in the proper field in the popup window that appears on-screen, and
3. Enter your preferred email address in the proper field too.

That's it. Thanks.

Team Utah Money Watch